Molecular remission of Philadelphia/brc-abl-positive acute myeloid leukaemia after treatment with anti-CD 33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676)

  • MP Vetten
  • , JH (Joop) Jansen
  • , BA Reijden
  • , MS Berger
  • , Mark Zijlmans
  • , Bob Löwenberg

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)277-279
Number of pages3
JournalBritish Journal of Haematology
Volume111
DOIs
Publication statusPublished - 2000

Research programs

  • EMC MM-02-41-03

Cite this